Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance

Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin... Abstract Adipose tissue expresses tumor necrosis factor (TNF) and interleukin (IL)-6, which may cause obesity-related insulin resistance. We measured TNF and IL-6 expression in the adipose tissue of 50 lean and obese subjects without diabetes. Insulin sensitivity (S I ) was determined by an intravenous glucose tolerance test with minimal-model analysis. When lean body mass index (BMI) <25 kg/m 2 and obese (BMI 30–40 kg/m 2 ) subjects were compared, there was a 7.5-fold increase in TNF secretion ( P < 0.05) from adipose tissue, and the TNF secretion was inversely related to S I ( r = −0.42, P < 0.02). IL-6 was abundantly expressed by adipose tissue. In contrast to TNF, plasma (rather than adipose) IL-6 demonstrated the strongest relationship with obesity and insulin resistance. Plasma IL-6 was significantly higher in obese subjects and demonstrated a highly significant inverse relationship with S I ( r = −0.71, P < 0.001). To separate the effects of BMI from S I , subjects who were discordant for S I were matched for BMI, age, and gender. By use of this approach, subjects with low S I demonstrated a 3.0-fold increased level of TNF secretion from adipose tissue and a 2.3-fold higher plasma IL-6 level ( P < 0.05) compared with matched subjects with a high S I . Plasma IL-6 was significantly associated with plasma nonesterified fatty acid levels ( r = 0.49, P < 0.002). Thus the local expression of TNF and plasma IL-6 are higher in subjects with obesity-related insulin resistance. type 2 diabetes Footnotes This study was supported by a Veterans Affairs Department Merit Review Grant M01-RR-14288 of the General Clinical Research Center, a Career Development Award from the American Diabetes Association, and DK-39176 from the National Institutes of Health. Address for reprint requests and other correspondence: P. A. Kern, Central Arkansas Veterans Healthcare System, 598/151 LR 4300 West 7th St., Little Rock, AR 72205 (E-mail: KernPhilipA@uams.edu ). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “ advertisement ” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Copyright © 2001 the American Physiological Society http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png AJP - Endocrinology and Metabolism The American Physiological Society

Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance

Download PDF
8 pages

Loading next page...
 
/lp/the-american-physiological-society/adipose-tissue-tumor-necrosis-factor-and-interleukin-6-expression-in-vuQJGhoZun

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
The American Physiological Society
Copyright
Copyright © 2011 the American Physiological Society
ISSN
0193-1849
eISSN
1522-1555
Publisher site
See Article on Publisher Site

Abstract

Abstract Adipose tissue expresses tumor necrosis factor (TNF) and interleukin (IL)-6, which may cause obesity-related insulin resistance. We measured TNF and IL-6 expression in the adipose tissue of 50 lean and obese subjects without diabetes. Insulin sensitivity (S I ) was determined by an intravenous glucose tolerance test with minimal-model analysis. When lean body mass index (BMI) <25 kg/m 2 and obese (BMI 30–40 kg/m 2 ) subjects were compared, there was a 7.5-fold increase in TNF secretion ( P < 0.05) from adipose tissue, and the TNF secretion was inversely related to S I ( r = −0.42, P < 0.02). IL-6 was abundantly expressed by adipose tissue. In contrast to TNF, plasma (rather than adipose) IL-6 demonstrated the strongest relationship with obesity and insulin resistance. Plasma IL-6 was significantly higher in obese subjects and demonstrated a highly significant inverse relationship with S I ( r = −0.71, P < 0.001). To separate the effects of BMI from S I , subjects who were discordant for S I were matched for BMI, age, and gender. By use of this approach, subjects with low S I demonstrated a 3.0-fold increased level of TNF secretion from adipose tissue and a 2.3-fold higher plasma IL-6 level ( P < 0.05) compared with matched subjects with a high S I . Plasma IL-6 was significantly associated with plasma nonesterified fatty acid levels ( r = 0.49, P < 0.002). Thus the local expression of TNF and plasma IL-6 are higher in subjects with obesity-related insulin resistance. type 2 diabetes Footnotes This study was supported by a Veterans Affairs Department Merit Review Grant M01-RR-14288 of the General Clinical Research Center, a Career Development Award from the American Diabetes Association, and DK-39176 from the National Institutes of Health. Address for reprint requests and other correspondence: P. A. Kern, Central Arkansas Veterans Healthcare System, 598/151 LR 4300 West 7th St., Little Rock, AR 72205 (E-mail: KernPhilipA@uams.edu ). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “ advertisement ” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Copyright © 2001 the American Physiological Society

Journal

AJP - Endocrinology and Metabolism – The American Physiological Society

Published: May 1, 2001

There are no references for this article.